Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues

Prostate

Volumn 75, Issue 7, 2015, Pages 735-747

  Mousavi, Samira ^a   Panjehpour, Mojtaba ^a   Izadpanahi, Mohammad Hossein ^b   Aghaei, Mahmoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

adenosine receptor(s); androgen receptor; prostate cancer; real time RT PCR; western blot

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ANDROGEN RECEPTOR; COMPLEMENTARY DNA; MESSENGER RNA; RNA;

ANDROGEN THERAPY; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LNCAP CELL LINE; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TISSUES; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PROSTATE TUMOR; TUMOR CELL LINE;

AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P1; RNA, NEOPLASM;

EID: 84926517252     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22955     Document Type: Article

References (69)

1. Fredholm BB, Jacobson AP, Linden KA, Müller J,. International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 2011; 63 (1): 1-34.
2. Gao Z-G, Jacobson KA,. Emerging adenosine receptor agonists-an update. Expert Opin Emerg Drugs 2011; 16 (4): 597-602.
3. Mustafa SJ, Morrison RR, Teng B, Pelleg A,. Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology. Adenosine receptors in health and disease. Handb Exp Pharmacol 2009;(193): 161-188.
4. Cunha RA, Ferré S, Vaugeois J-M, Chen J-F,. Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharm Des 2007; 14 (15): 1512-1524.
5. Kalda A, Yu L, Oztas E, Chen J-F,. Novel neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson's disease. J Neurol Sci 2006; 248 (1): 9-15.
6. Schiffmann SN, Fisone G, Moresco R, Cunha R, Ferré S,. Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 2007; 83 (5): 277-292.
7. Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF,. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiology & behavior. 2007; 92 (1): 210-217.
8. Ralevic V, Burnstock G,. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50 (3): 413-492.
9. Brambilla R, Cattabeni F, Ceruti S, Barbieri D, Franceschi C, Kim YC, Jacobson KA, Klotz KN, Lohse MJ, Abbracchio MP, et al. Activation of the A3 adenosine receptor affects cell cycle progression and cell growth. Naunyn Schmiedeberg's Arch Pharmacol 2000; 361 (3): 225-234.
10. Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz K-N, et al. Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol 2002; 119 (4): 923-933.
11. Schiedel AC, Lacher SK, Linnemann C, Knolle PA, Müller CE,. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: Evidence for receptor-independent mechanisms. Purinergic signal 2013; 9 (3): 351-365.
12. Blay J, White TD, Hoskin DW,. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 1997; 57 (13): 2602-2605.
13. Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-Yasenetskaya T, et al. Differential expression of adenosine receptors in human endothelial cells role of A2B receptors in angiogenic factor regulation. Circ Res 2002; 90 (5): 531-538.
14. Gessi S, Merighi S, Sacchetto V, Simioni C, Borea PA,. Adenosine receptors and cancer. Biochim Biophys Acta 2011; 1808 (5): 1400-1412.
15. Khoo H-E, Ho C-L, Chhatwal VJ, Chan ST, Ngoi S-S, Moochhala SM,. Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett 1996; 106 (1): 17-21.
16. Gessi S, Varani K, Merighi S, Morelli A, Ferrari D, Leung E, et al. Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. Br J Pharmacol 2001; 134 (1): 116-126.
17. Merighi S, Varani K, Gessi S, Cattabriga E, Iannotta V, Ulouglu C, et al. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br J Pharmacol 2001; 134 (6): 1215-1226.
18. Mirza A, Basso A, Black S, Malkowski M, Kwee L, Pachter JA, et al. Research paper RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biol Ther 2005; 4 (12): 1355-1360.
19. Kalhan A, Gharibi B, Vazquez M, Jasani B, Neal J, Kidd M, et al. Adenosine A2A and A2B receptor expression in neuroendocrine tumours: Potential targets for therapy. Purinergic Signal 2012; 8 (2): 265-274.
20. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci 2006; 103 (35): 13132-13137.
21. Ma D-F, Kondo T, Nakazawa T, Niu D-F, Mochizuki K, Kawasaki T, et al. Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells. Hum Pathol 2010; 41 (11): 1550-1557.
22. H-j Xiang, Liu Z-c, Wang D-s, Chen Y, Yang Y-l, Dou K-f,. Adenosine A 2b receptor is highly expressed in human hepatocellular carcinoma. Hepatol Res 2006; 36 (1): 56-60.
23. Panjehpour M, Movahedian A, Sadeghi H, Eghbali B, Yekdaneh A,. Adenosine receptor expression in two different human cancer cell Lines at molecular level. Iran J Cancer Prev 2012; 3 (3): 111-116.
24. Feoktistov I, Ryzhov S, Goldstein AE, Biaggioni I,. Mast cell-mediated stimulation of angiogenesis cooperative interaction between A2B and A3 adenosine receptors. Circ Res 2003; 92 (5): 485-492.
25. Zeng D, Maa T, Wang U, Feoktistov I, Biaggioni I, Belardinelli L,. Expression and function of A2B adenosine receptors in the U87MG tumor cells. Drug Dev Res 2003; 58 (4): 405-411.
26. Ryzhov S, Novitskiy SV, Zaynagetdinov R, Goldstein AE, Carbone DP, Biaggioni I, et al. Host A2B adenosine receptors promote carcinoma growth. Neoplasia (New York, NY) 2008; 10 (9): 987.
27. Ishida M, Mitsui T, Yamakawa K, Sugiyama N, Takahashi W, Shimura H, et al. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture. Am J Physiol-Endocrinol Metab 2007; 293 (6): E1529-E1537.
28. Shaywitz AJ, Greenberg ME,. A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Ann Rev Biochem 1999; 68 (1): 821-861.
29. Darashchonak N, Koepsell B, Bogdanova N, von Versen-Höynck F,. Adenosine A2B receptors induce proliferation, invasion and activation of cAMP response element binding protein (CREB) in trophoblast cells. BMC Pregnancy Childbirth 2014; 14 (1): 2.
30. Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J,. Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 2012; 188 (1): 198-205.
31. Morello S, Miele L,. Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells. OncoImmunology 2014; 3 (1): e.
32. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP,. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J 2006; 20 (13): 2242-2250.
33. Yang M, Ma C, Liu S, Shao Q, Gao W, Song B, et al. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol Cell Biol 2010; 88 (2): 165-171.
34. Kohno Y, Sei Y, Koshiba M, Kim HO, Jacobson KA,. Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A 3 receptor agonists. Biochem Biophys Res Comm 1996; 219 (3): 904-910.
35. Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, et al. The A3 adenosine receptor is highly expressed in tumor versus normal cells potential target for tumor growth inhibition. Clin Cancer Res 2004; 10 (13): 4472-4479.
36. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63 (1): 11-30.
37. Janssens R, Boeynaems JM,. Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 2001; 132 (2): 536-546.
38. Koong LY, Watson CS,. Direct estradiol and diethylstilbestrol actions on early-versus late-stage prostate cancer cells. Prostate 2014; 74 (16): 1589-1603.
39. Tan ME, Li J, Xu HE, Melcher K, Yong E-l,. Androgen receptor: Structure, role in prostate cancer and drug discovery. Acta Pharmacol Sinica 2015; 36: 3-23.
40. Otsuka T, Hamada A, Iguchi K, Usui S, Hirano K,. Suppression of metallothionein 3 gene expression by androgen in LNCaP prostate cancer cells. Biomed Reports. 2013; 1 (4): 614-618.
41. Xu Y, Chen S-Y, Ross KN, Balk SP,. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res 2006; 66 (15): 7783-7792.
42. Xu B, Tang G, Xiao C, Wang L, Yang Q, Sun Y,. Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers. Int J Clin Exp Pathol 2014; 7 (6): 2883.
43. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative CT method. Nature protocols. 2008; 3 (6): 1101-1108.
44. Jackson DA, Pombo A, Iborra F,. The balance sheet for transcription: an analysis of nuclear RNA metabolism in mammalian cells. FASEB J 2000; 14 (2): 242-254.
45. Zhao P, Li X-g, Yang M, Shao Q, Wang D, Liu S, et al. Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A 2b via cAMP/PKA signaling pathway. Mol Immunol 2008; 45 (8): 2187-2195.
46. Feoktistov I, Ryzhov S, Zhong H, Goldstein AE, Matafonov A, Zeng D, et al. Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 2004; 44 (5): 649-654.
47. Xaus J, Mirabet M, Lloberas J, Soler C, Lluis C, Franco R, et al. IFN-γ up-regulates the A2B adenosine receptor expression in macrophages: A mechanism of macrophage deactivation. J Immunol 1999; 162 (6): 3607-3614.
48. Mirabet M, Herrera C, Cordero OJ, Mallol J, Lluis C, Franco R,. Expression of A2B adenosine receptors in human lymphocytes: Their role in T cell activation. J Cell Sci 1999; 112 (4): 491-502.
49. Minelli A, Bellezza I, Tucci A, Rambotti MG, Conte C, Culig Z,. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells. The Prostate 2009; 69 (5): 538-547.
50. Wei Q, Costanzi S, Balasubramanian R, Gao Z-G, Jacobson KA,. A2B adenosine receptor blockade inhibits growth of prostate cancer cells. Purinergic Signal 2013; 9 (2): 271-280.
51. Aghaei M, Karami-Tehrani F, Panjehpour M, Salami S, Fallahian F,. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and-independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3. The Prostate 2012; 72 (4): 361-375.
52. Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E, et al. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation. Cancer Biol Ther 2008; 7 (2): 278.
53. Gessi S, Cattabriga E, Avitabile A, Lanza G, Cavazzini L, Bianchi N, et al. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 2004; 10 (17): 5895-5901.
54. Gessi S, Merighi S, Varani K, Cattabriga E, Benini A, Mirandola P, et al. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine subtype. J Cell Physiol 2007; 211 (3): 826-836.
55. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, et al. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells. J Biol Chem 2005; 280 (20): 19516-19526.
56. Gessi S, Varani K, Merighi S, Cattabriga E, Avitabile A, Gavioli R, et al. Expression of A3 adenosine receptors in human lymphocytes: Up-regulation in T cell activation. Mol Pharmacol 2004; 65 (3): 711-719.
57. Dubey RK, Gillespie DG, Jackson EK,. A2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 2002; 39 (2): 530-535.
58. Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, et al. Targeting the A3 adenosine receptor for cancer therapy: Inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 2003; 23 (3): 2077-2084.
59. Ohana G, Bar-Yehuda S, Arich A, Madi L, Dreznick Z, Rath-Wolfson L, et al. Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer 2003; 89 (8): 1552-1558.
60. Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P,. A3 adenosine receptor activation in melanoma cells associatin between receptor fate and tumor growth inhibition. J Biol Chem 2003; 278 (43): 42121-42130.
61. Aghaei M, Panjehpour M, Karami-Tehrani F, Salami S,. Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: Involvement of intrinsic pathway. J Cancer Res Clin Oncol 2011; 137 (10): 1511-1523.
62. Jajoo S, Mukherjea D, Watabe K, Ramkumar V,. Adenosine A3 receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity. Neoplasia (New York. NY). 2009; 11 (11): 1132.
63. Panjehpour M, Castro M, Klotz KN,. Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal. Br J Pharmacol 2005; 145 (2): 211-218.
64. Panjehpour M, Karami-Tehrani F,. Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors. Oncol Res Featuring Preclin Clin Cancer Ther 2007; 16 (12): 575-585.
65. Liu T-z, Wang X, Y-f Bai, H-z Liao, S-c Qiu, Yang Y-q, et al. The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. Int J Biochem Cell Biol 2014; 49: 8-16.
66. Lukashev D, Ohta A, Sitkovsky M,. Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 2007; 26 (2): 273-279.
67. Sun D, Layer R, Mueller A, Cichewicz M, Negishi M, Paschal B, et al. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene 2013; 33 (11): 1448-1457.
68. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, et al. Hormonal regulation of β2-adrenergic receptor level in prostate cancer. The Prostate 2008; 68 (10): 1133-1142.
69. Perron L, Bairati I, Harel F, Meyer F,. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 2004; 15 (6): 535-541.